BRCA1 rs321029: Understanding This Genetic Marker
The rs321029 variant is a single-nucleotide polymorphism located within the BRCA1 gene. It is a common genetic marker that has been investigated in scientific studies for its potential association with breast and ovarian cancer susceptibility.
What each genotype means
Typical genetic marker profile
This genotype represents the common homozygous state for this variant. Research into this specific marker in the BRCA1 gene is ongoing, and current evidence does not suggest this genotype significantly alters breast or ovarian cancer risk on its own. As with all genetic findings, this should be viewed as one small piece of a much larger health picture.
This is a common genotype found across most global populations.
Typical genetic marker profile
This genotype represents the heterozygous state for this variant. Current scientific literature classifies this marker as having a moderate or uncertain association with cancer susceptibility, meaning it is not considered a primary driver of risk. You should discuss your overall health history and any family concerns with a healthcare provider rather than focusing on this specific result.
This genotype is frequently observed in diverse populations worldwide.
Typical genetic marker profile
This genotype represents the homozygous state for the alternative allele of this variant. While this SNP has been investigated for potential links to cancer susceptibility, the evidence remains limited and does not indicate a strong or direct clinical impact. This result should not be used to make medical decisions or to assess individual cancer risk.
This genotype is present at varying frequencies depending on ancestral background but is considered a common variant.
What is rs321029 and Where is it Located?
The rs321029 variant is a specific change in the DNA sequence, known as a single-nucleotide polymorphism (SNP), located within the BRCA1 gene. The BRCA1 gene is situated on chromosome 17 at position 17q21.31. In the context of genetic research, SNPs like rs321029 serve as markers that scientists use to study variations across the human genome. Because this variant is located within a gene that is critical for DNA repair, researchers have focused on it to determine if it influences how the body maintains genomic stability. It is important to note that being a marker does not automatically mean the variant itself causes a disease; rather, it is a point of interest for researchers studying the complex genetic architecture of cancer risk.
The Role of the BRCA1 Gene
The BRCA1 gene, which stands for Breast Cancer gene 1, provides instructions for making a protein that acts as a tumor suppressor. This protein is essential for repairing damaged DNA, which helps maintain the stability of a cell's genetic information. When the BRCA1 protein functions correctly, it prevents cells from growing and dividing too rapidly or in an uncontrolled way. Mutations that significantly disrupt the function of this gene are well-documented to increase the risk of developing certain cancers, particularly breast and ovarian cancer. Because of its vital role in cellular health, any variation within or near this gene, such as rs321029, is often scrutinized by the scientific community to see if it might subtly alter the gene's expression or the protein's efficiency in DNA repair processes.
Research Associations and Evidence Strength
The evidence linking rs321029 to cancer susceptibility is currently classified as moderate. While the BRCA1 gene is famously associated with hereditary cancer syndromes, most of those associations involve rare, high-impact mutations. In contrast, rs321029 is a common variant, and its role is generally investigated as a potential 'modifier'—a genetic factor that might slightly increase or decrease risk rather than acting as a primary cause of disease. Scientific studies, including those found in the GWAS Catalog, have looked at this SNP to see if it correlates with cancer outcomes in large populations. However, results can be mixed and often vary between different ancestral groups. Because the evidence is not definitive, it is considered a marker for further investigation rather than a diagnostic tool for clinical risk assessment.
Population Frequency
The rs321029 variant is considered a common SNP, meaning it appears frequently across diverse human populations. Unlike rare, pathogenic mutations in BRCA1 that are found in a very small percentage of the population, common variants like rs321029 are present in a significant portion of healthy individuals. Because it is common, it is often used in large-scale genetic studies to help researchers understand the baseline variation of the BRCA1 gene across different ethnicities. While its frequency is well-documented in databases like gnomAD, the clinical significance of this frequency remains a subject of ongoing research, as common variants typically have much smaller individual effects on health outcomes compared to rare, high-penetrance mutations.
What You Can and Cannot Do With This Information
It is important to understand that genetic information regarding common variants like rs321029 is intended for educational purposes and scientific research. You cannot use this information to diagnose yourself with a medical condition or to predict your personal risk of developing cancer. Genetic markers are only one piece of a very large puzzle that includes family history, lifestyle, and environmental factors. If you have concerns about your personal or family history of cancer, the most appropriate step is to consult with a healthcare professional or a certified genetic counselor. They can provide context based on your specific medical history and guide you through appropriate screening or testing options. Never make changes to your health management or medical decisions based solely on information about a single genetic variant.
How common is this variant?
The rs321029 variant is a common polymorphism found across diverse global populations, with its specific genotype frequencies varying by ancestry.
Frequently asked questions
Is rs321029 a sign that I have a BRCA1 mutation?
No, rs321029 is a common genetic variant, not a pathogenic mutation. Pathogenic BRCA1 mutations are rare and are associated with significantly higher risks of cancer, whereas this SNP is a common marker found in many healthy individuals.
Should I get tested for rs321029?
Testing for common variants like rs321029 is generally not recommended for clinical purposes because it does not provide actionable medical information. If you are concerned about your cancer risk, speak with a doctor about clinical genetic testing for high-risk mutations.
Does this variant mean I will get breast cancer?
No, having this variant does not mean you will develop cancer. Cancer risk is complex and influenced by many factors, including your overall genetic profile, family history, and lifestyle choices.
Where can I find more information about BRCA1 variants?
You can explore resources like MedlinePlus Genetics or the NCBI ClinVar database for reliable information on gene variants. Always discuss any specific genetic findings with a qualified healthcare provider.
Sources & further reading
Educational information only, last refreshed 10/3/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs321029?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BRCA1
This rare variant has been recently annotated in clinical databases as a potential contributor to hereditary breast and ovarian cancer risk.
Variant identified in polygenic risk scores for breast cancer susceptibility.
A very rare variant identified in recent genomic studies, currently being investigated for potential associations with reproductive phenotypes.
This variant is a rare genetic alteration in the BRCA1 gene, which is critical for DNA repair and associated with hereditary breast and ovarian cancer syndromes impacting reproductive health.
A rare variant located in the BRCA1 gene, relevant to reproductive genetic counseling and the assessment of hereditary cancer risk.
This BRCA1 variant (p.Pro871Leu) is a common polymorphism often evaluated in breast cancer risk studies, though it is generally considered to have no clinical significance for hereditary breast and ovarian cancer syndrome.